These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1903951)

  • 1. Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
    Millward MJ; Cantwell BM; Dowsett M; Carmichael J; Harris AL
    Br J Cancer; 1991 May; 63(5):763-4. PubMed ID: 1903951
    [No Abstract]   [Full Text] [Related]  

  • 2. The minimal effective exemestane dose for endocrine activity in advanced breast cancer.
    Bajetta E; Zilembo N; Noberasco C; Martinetti A; Mariani L; Ferrari L; Buzzoni R; Greco M; Bartoli C; Spagnoli I; Danesini GM; Artale S; Paolini J
    Eur J Cancer; 1997 Apr; 33(4):587-91. PubMed ID: 9274439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
    Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
    Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of serum testosterone-estradiol-binding globulin, follicular stimulating hormone, luteinizing hormone, estradiol, progesterone, and testosterone levels in women associated with aging].
    Kamatsuki S
    Igaku Kenkyu; 1982 Nov; 52(5):243-55. PubMed ID: 6821181
    [No Abstract]   [Full Text] [Related]  

  • 5. Goserelin in premenopausal advanced breast cancer: clinical and endocrine evaluation of responsive patients.
    Bajetta E; Zilembo N; Buzzoni R; Celio L; Zampino MG; Colleoni M; Oriana S; Attili A; Sacchini V; Martinetti A
    Oncology; 1994; 51(3):262-9. PubMed ID: 8196909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patients.
    Dowsett M; Mehta A; Mansi J; Smith IE
    Br J Cancer; 1990 Nov; 62(5):834-7. PubMed ID: 2123115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dietery weight loss on sex steroid binding sex steroids, and gonadotropins in obese postmenopausal women.
    O'Dea JP; Wieland RG; Hallberg MC; Llerena LA; Zorn EM; Genuth SM
    J Lab Clin Med; 1979 Jun; 93(6):1004-8. PubMed ID: 571447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
    Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
    Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma FSH and LH in post-menopausal women with breast cancer.
    Wang DY; Goodwin PR; Bulbrook RD; Hayward JL
    Eur J Cancer (1965); 1976 Apr; 12(4):305-11. PubMed ID: 954791
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer.
    Bird CE; Cook S; Owen S; Sterns EE; Clark AF
    Oncology; 1981; 38(6):365-8. PubMed ID: 6795556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum oestradiol-17 beta, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer.
    Ribeiro GG; Phillips HV; Skinner LG
    Br J Cancer; 1980 Mar; 41(3):474-7. PubMed ID: 6770883
    [No Abstract]   [Full Text] [Related]  

  • 12. Droloxifene, a new antiestrogen. Hormonal influences in postmenopausal breast cancer patients.
    Kvinnsland S
    Am J Clin Oncol; 1991; 14 Suppl 2():S46-51. PubMed ID: 1962597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Buserelin therapy in postmenopausal patients with advanced breast carcinoma].
    Vici P; Veltri E; Carpano S; Di Lauro L; Lopez M
    Clin Ter; 1991 Feb; 136(3):195-9. PubMed ID: 1827382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients.
    Ellmén J; Werner D; Hakulinen P; Keiling R; Fargeot P; Falkson G; Bezwoda WR
    Cancer Chemother Pharmacol; 2000; 45(5):402-8. PubMed ID: 10803924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
    Blackburn AM; Wang DY; Bulbrook RD; Thomas BS; Kwa HG; Hoare SA; Rubens RD
    Cancer Treat Rep; 1984 Dec; 68(12):1447-53. PubMed ID: 6239689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merits and considerations in the use of anti-androgen.
    Rao BR; de Voogt HJ; Geldof AA; Gooren LJ; Bouman FG
    J Steroid Biochem; 1988 Oct; 31(4B):731-7. PubMed ID: 3143862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
    Williams MR; Walker KJ; Turkes A; Blamey RW; Nicholson RI
    Br J Cancer; 1986 May; 53(5):629-36. PubMed ID: 2941044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer.
    Kyvernitakis I; Albert US; Kalder M; Winarno AS; Hars O; Hadji P
    Climacteric; 2015 Feb; 18(1):63-8. PubMed ID: 24884402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroids and pulsatile luteinizing hormone release in men. Studies in estrogen-treated agonadal subjects and eugonadal subjects treated with a novel nonsteroidal antiandrogen.
    Gooren L; Spinder T; Spijkstra JJ; van Kessel H; Smals A; Rao BR; Hoogslag M
    J Clin Endocrinol Metab; 1987 Apr; 64(4):763-70. PubMed ID: 3102546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer.
    Howell A; DeFriend DJ; Robertson JF; Blamey RW; Anderson L; Anderson E; Sutcliffe FA; Walton P
    Br J Cancer; 1996 Jul; 74(2):300-8. PubMed ID: 8688341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.